Chris Evans: Radio DJ reveals skin cancer diagnosis
The broadcaster, 57, urged his Virgin Radio listeners to get themselves checked. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 21, 2023 Category: Consumer Health News Source Type: news
Six bizarre signs of skin cancer revealed after radio legend Chris Evans' diagnosis
The 57-year-old today told listeners of his Virgin Radio show that his melanoma was found in the extremely early stages and he is hoping to make a full recovery. (Source: the Mail online | Health)
Source: the Mail online | Health - August 21, 2023 Category: Consumer Health News Source Type: news
Radio presenter Chris Evans diagnosed with skin cancer
The broadcaster Chris Evans has revealed he has been diagnosed with skin cancer. Speaking on his Virgin Radio show on Monday morning, he confirmed the disease was discovered in the early stages and that he was told it is treatable. He said: “We need to discuss what’s going on with this issue. It…#chrisevans #virginradio #bbcradio2s #oneshowandtopgear #channel4 #bigbreakfast (Source: Reuters: Health)
Source: Reuters: Health - August 21, 2023 Category: Consumer Health News Source Type: news
You should be wearing scalp sunscreen
While you’ve probably heard that you need to lather up your face and body with sunscreen to protect your skin from the sun’s rays, you probably aren’t thinking about the top of your head. The scalp is a high risk area when it comes to sun exposure — and if damage like skin cancer is found on the…#clairewolinsky #newyorkcity #michelegreen #chemical #spfprotection #jamiederosa #neutrogena #eileendeignan #emersonhospital #sunbum (Source: Reuters: Health)
Source: Reuters: Health - August 19, 2023 Category: Consumer Health News Source Type: news
Immunotherapy drug combo helps extend lives of people with metastatic melanoma
A research team co-led by UCLA investigators has shown that an immunotherapy drug combination can be an effective second-line therapy for patients with an aggressive and deadly type of melanoma that is resistant to widely used immunotherapy drugs called PD-1 inhibitors.In clinical trials, the investigators found that the combination therapy could extend the amount of time patients live without their cancer worsening, known as progression-free survival, and that it helps overcome their resistance to prior immunotherapies — which would allow more people to benefit from the treatment.The study evaluated the use of the imm...
Source: UCLA Newsroom: Health Sciences - August 18, 2023 Category: Universities & Medical Training Source Type: news
Episode 4: Liquid Biopsy in Melanoma Episode 4: Liquid Biopsy in Melanoma
Drs Sapna Patel and David Polsky explore biomarker development and the clinical utilization of liquid biopsy in melanoma.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
I was diagnosed with skin cancer. All I cared about was my looks
The dermatologist called with the results of my biopsy. I was not expecting her to say: "You have skin cancer." She explained that the spot under my left eye would have to be surgically removed. I was shocked and hung up the phone in tears. I continued to feel depressed and stressed for weeks.…#flawless #burundi #afghanistan #uganda #rebekahburroway #stonybrookuniversity (Source: Reuters: Health)
Source: Reuters: Health - August 16, 2023 Category: Consumer Health News Source Type: news
Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT ™ for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
HEPZATO KIT is the only FDA approved liver-directed therapy to treat metastatic uveal melanoma Approval includes treatment naïve and previously treated patients and is not limited by HLA genotype Delcath to hold Business Update Call on August 15, 2023 at 8:00 a.m. Eastern Time NEW YORK, Aug. 14,…#hepzatokit #fda #businessupdatecall #easterntime #delcathsystems #nccn #php #hepzatokitmarks #gerardmichel #nct02678572 (Source: Reuters: Health)
Source: Reuters: Health - August 16, 2023 Category: Consumer Health News Source Type: news
FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma
(MedPage Today) -- The FDA announced approval of the Hepzato Kit melphalan injection system as liver-directed therapy for uveal melanoma metastases.
The approval stipulates use in adults with unresectable liver metastases that affects less than... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 15, 2023 Category: American Health Source Type: news
FDA approves melphalan as a liver-directed treatment for uveal melanoma
On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System) containing melphalan (HEPZATO, Delcath Systems, Inc.) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 15, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Taking Snapshots of DNA Damage in Skin Cancer
Researchers turn to high resolution sequencing to explain recurrent melanoma mutations caused by UV exposure. (Source: The Scientist)
Source: The Scientist - August 15, 2023 Category: Science Tags: News News & Opinion Source Type: news
Mayo Clinic Q and A: 5 advances in cancer treatment
DEAR MAYO CLINIC: In the past year, several family members have been diagnosed with various types of cancer, including leukemia, melanoma, breast cancer and colon cancer. In talking about treatments, it seems as if there is more available today than in the past. Can you share some of the advances in cancer care? What should I know as far as my risk for cancer? ANSWER: Although the rate of cancer diagnosis has fallen slightly post-COVID-19, cancer remains… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 15, 2023 Category: Databases & Libraries Source Type: news
FDA Approves Hepzato Kit (melphalan) Hepatic Delivery System for the Treatment of Unresectable Hepatic-Dominant Metastatic Uveal Melanoma
NEW YORK, Aug. 14, 2023 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced that today the US Food and Drug Administration... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 14, 2023 Category: Drugs & Pharmacology Source Type: news
AI Pipeline Can Accurately Measure Sarcopenia in Head and Neck Cancer
MONDAY, Aug. 14, 2023 -- A fully automated deep learning pipeline can accurately measure sarcopenia in head and neck squamous cell carcinoma (HNSCC), which is associated with disease outcomes, according to a study published online Aug. 10 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 14, 2023 Category: Pharmaceuticals Source Type: news
More Intensive Imaging Follow-Up in Head, Neck Cancer? More Intensive Imaging Follow-Up in Head, Neck Cancer?
Patients with advanced head and neck squamous cell carcinoma demonstrated improved overall survival with intensive post-treatment follow-up monitoring with 18F- FDG-PET/CT vs conventional follow-up.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 11, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
